• Home
  • Ongoing Clinical Studies

Ongoing Clinical Studies

Filter Clinical Studies by:

Name

Physician(s)

all-types

Name

A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases ›

Physician(s)

Frank A. Vicini, MD
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR

Name

A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation ›

Physician(s)

Troy H. Guthrie, Jr., MD

Blood

Name

A Disease Registry for Patients with Chronic Lymphocytic Leukemia ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

A phase III, randomised, open-label, comparative safety and efficacy trial of in-travenous iron isomaltoside (Monofer®) and iron sucrose in subjects with iron deficiency anaemia who are intolerant or unresponsive to oral iron therapy or in whom the haemoglobin measurement in Investigators' opinion were sufficiently low as to require rapid repletion of iron stores to minimize the risk of receiving a blood transfusion ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

Prospective, Longitudinal, Non-Interventional Study Of Disease Burden And Treatment Of Patients With Low-Risk Myelofibrosis (MF) Or High-Risk Essential Thrombocythemia (ET) Or ET Patients Receiving ET-Directed Therapy  ›

Physician(s)

Troy H. Guthrie, Jr., MD

Brain-Cancer

Name

A Randomized, Phase III Trial Of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases ›

Physician(s)

Frank A. Vicini, MD
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR

Breast-Cancer

Name

A Phase IIR/III Trial of Standard of Care with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer ›

Physician(s)

Frank A. Vicini, MD
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR

Name

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy ›

Physician(s)

Frank A. Vicini, MD
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR

Name

MROQC ›

Physician(s)

Larry L. Kestin, MD

Gastric-Cancer

Name

Randomized, Double-Blind, Phase 3 Study Evaluating Tas-102 Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc In Patients With Metastatic Gastric Cancer Refractory To Standard Treatments ›

Physician(s)

Troy H. Guthrie, Jr., MD

Back
To top